Literature DB >> 200198

Location of antigens associated with bovine leukemia virus.

M Onuma, D M Driscoli, C Olson.   

Abstract

Antigens associated with bovine leukemia virus (BLV) infection (gp 44/55 and p23) were identified by neutralization and immunofluorescent antibody (FA) tests. Only serums containing antibody to gp 45/55 neutralized the virus; antibody to p23 did not. These results indicate that gp 44/55 may be located in the virus envelope. In indirect FA tests, both a cytoplasmic fluorescence and a membrane fluorscence were detected in BLV-infected cells. The serum used in the FA test was then absorbed with either p23 or gp 45/55. The results of these absorption tests indicate that the membrane fluorescence maybe associated with gp 45/55 and the cytoplasmic fluorescence may be associated with p23.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200198     DOI: 10.1007/bf01314486

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors:  M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.

Authors:  G Pearson; F Dewey; G Klein; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1970-11       Impact factor: 13.506

3.  Replicating type-C virus particles in monolayer cell cultures of tissues from cattle with lymphosarcoma.

Authors:  M J Van Der Maaten; J M Miller; A D Boothe
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

4.  Serological detection of type C viruses found in bovine cultures.

Authors:  J F Ferrer; L Avila; N D Stock
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

5.  Properties of two isolated antigens associated with bovine leukemia virus infection.

Authors:  M Onuma; C Olson; D M Driscoll
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

6.  Characteristics of the major internal protein and RNA-dependent DNA polymerase of bovine leukaemia virus.

Authors:  R V Gilden; C W Long; M Hanson; R Toni; H P Charman; S Oroszlan; J M Miller; M J Van der Maaten
Journal:  J Gen Virol       Date:  1975-12       Impact factor: 3.891

7.  Tumor-associated antigen in bovine and ovine lymphosarcoma.

Authors:  M Onuma; C Olson
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

8.  Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein.

Authors:  R A Steeves; M Strand; J T August
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

9.  Studies on the relationship between infection with bovine C-type virus, leukemia, and persistent lymphocytosis in cattle.

Authors:  J F Ferrer; D A Abt; D M Bhatt; R R Marshak
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

10.  Common cell surface antigen associated with mammalian C-type RNA viruses. Cell membrane-bound gs antigen.

Authors:  T Yoshiki; R C Mellors; W D Hardy; E Fleissner
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

View more
  3 in total

1.  Inhibition of bovine leukemia virus release by antiviral antibodies.

Authors:  D M Driscoll; M Onuma; C Olson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Cytotoxic antibody in cattle and sheep exposed to bovine leukemia virus.

Authors:  T Honma; M Onuma; M Suneya; T Mikami; H Izawa
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Transformed phenotypes in long-term cultures persistently infected with bovine leukemia virus.

Authors:  M Onuma; K Matsumoto; R Moriguchi; Y Fujimoto; Y Miyake; T Mikami; H Izawa
Journal:  Can J Comp Med       Date:  1981-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.